← Eichor
Study identifier: NCT06811935 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

PEDI Pediatric Autoimmune Neuropsychiatric Disorder Associated With Streptococcus Study

Condition: PANS · PANDAS  ·  Sponsor: University of Wisconsin, Madison

PhaseN/A
Planned participants30
Who can joinAll sexes, 3 Years to 17 Years
Healthy volunteersNo

About this study

The objective of the Pediatric Epidemiological Data and Incidence (PEDI) PANDAS study is to demonstrate the feasibility of enrollment and retention of subjects in a study to determine the incidence and natural history of children with Pediatric Acute-Onset Neuropsychiatric Syndrome (PANS) with regard to spectrum, course and outcome. The investigators aim to demonstrate they can recruit and retain 85% of children who are eligible for this study. Eligible children are those who fit criteria for PANS and Pediatric Autoimmune Neuropsychiatric Disorder Associated with Streptococcus (PANDAS). Each child will be followed for one year.

This description comes directly from the study's public registry record.

Talk to the study team

Pediatric Clinical Research Coordination  ·  (608) 228-4940  ·  researchnurses@pediatrics.wisc.edu

Always discuss trial participation with your own doctor first.

Locations (2)

Dartmouth Hitchcock Medical CenterLebanon, New Hampshire, United StatesRecruiting
UW School of Medicine and Public HealthMadison, Wisconsin, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06811935